Restoring vascular nitric oxide formation by l-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease
- 19 November 1998
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 32 (5) , 1336-1344
- https://doi.org/10.1016/s0735-1097(98)00375-1
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Adhesiveness of Mononuclear Cells in Hypercholesterolemic Humans Is Normalized by Dietary l -ArginineArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Elevatedl-Arginine/Dimethylarginine Ratio Contributes to Enhanced Systemic NO Production by Dietaryl-Arginine in Hypercholesterolemic RabbitsBiochemical and Biophysical Research Communications, 1996
- Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO productionAtherosclerosis, 1995
- The role of nitric oxide and other endothelium-derived vasoactive substances in vascular diseaseProgress in Cardiovascular Diseases, 1995
- L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans.Journal of Clinical Investigation, 1992
- Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit.Journal of Clinical Investigation, 1992
- Color and conventional image‐directed Doppler ultrasonography: Accuracy and sources of error in quantitative blood flow measurementsJournal of Clinical Ultrasound, 1992
- Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginineThe Lancet, 1991
- Large coronary arteries in humans are responsive to changing blood flow: An endothelium-dependent mechanism that fails in patients with atherosclerosisJournal of the American College of Cardiology, 1990
- Intermittent claudication: Not so benignAmerican Heart Journal, 1986